Pharming Group N.V. (PHAR)

Pharming Group Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-10.79	-10.55	13.67	16	37.75	40.56
Depreciation & Amortization	19.54	15.93	13.19	19.61	8.31	5.8
Share-Based Compensation	10.12	9.25	6.39	9.06	6.54	4.29
Other Operating Activities	-21.04	-31.93	-10.8	-6.82	31.03	23.51
Operating Cash Flow	-2.16	-17.3	22.46	37.84	83.63	74.15
Operating Cash Flow Growth	-	-	-40.65%	-54.75%	12.78%	83.05%
Capital Expenditures	-1.3	-1.44	-1.38	-10.74	-4.66	-2.65
Acquisitions	-	21.28	7.3	0	-0.33	-2.81
Change in Investments	-	-149.2	0	-4.59	0	0
Other Investing Activities	-127.21	-0.03	-0.6	-5.98	-10.64	-22.8
Investing Cash Flow	-128.51	-129.39	5.32	-21.31	-15.63	-28.26
Share Issuance / Repurchase	8.32	8.13	2.28	4.72	2.79	3.11
Debt Issued / Paid	-9.2	-9.17	-7.26	-7.67	78.62	-46.83
Other Financing Activities	-	-	-	-25	-20.72	-19.76
Financing Cash Flow	-0.88	-1.04	-4.98	-27.95	60.69	-63.47
Net Cash Flow	-131.55	-147.73	22.8	-11.41	128.68	-17.58
Free Cash Flow	-3.47	-18.74	21.08	27.1	78.97	71.5
Free Cash Flow Growth	-	-	-22.22%	-65.68%	10.44%	88.10%
Free Cash Flow Margin	-1.34%	-7.64%	10.25%	13.63%	37.22%	37.75%
Free Cash Flow Per Share	-0.05	-0.28	0.33	0.42	1.24	1.12

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).